What’s the latest on monoclonal antibody therapies to treat COVID-19?
Jan 12, 2022 · Here's more information on the two monoclonal antibody therapies that the FDA recommends and criteria for their use: Sotrovimab Sotrovimab is authorized to treat mild to moderate …
Monoclonal antibody treatment can help high-risk patients with COVID …
Dec 4, 2020 · Mayo Clinic is treating patients with COVID-19 with monoclonal antibody treatments. The Food and Drug Administration (FDA) issued an emergency use authorization to use bamlanivimab …
Monoclonal antibodies: Update on this COVID-19 experimental therapy
Feb 26, 2021 · Monoclonal antibody drugs can be used to boost the immune system's response or calm it down. They can be used alone or in combination with other monoclonal antibodies. Administering a …
Patients treated with monoclonal antibodies during COVID-19 delta …
Jun 27, 2022 · A study of 10,775 high-risk adult patients during the COVID-19 delta variant surge in late 2021 finds that treatment with one of three anti-spike neutralizing monoclonal antibodies for mild to …
Smoldering multiple myeloma: What it is, how it progresses and the ...
Apr 22, 2025 · What is smoldering multiple myeloma? The first phase of abnormal plasma cells building up in the bone marrow without causing symptoms or complications is a benign (noncancerous) …
Mayo Clinic study finds dysfunctional white blood cells linked to ...
Sep 5, 2024 · A Mayo Clinic study finds that people with a condition called monoclonal B-cell lymphocytosis (MBL) have a heightened melanoma risk.
Monoclonal antibody treatment helps couple recover quickly from …
Feb 23, 2021 · Monoclonal antibody is an experimental treatment for people at a higher risk of hospitalization due to COVID-19 and is part of an emergency use authorization from the Food and …
Mayo Clinic secures ARPA-H award to build a living pharmacy within …
Oct 2, 2024 · The researchers aim to develop a bioelectric device that carries genetically engineered cells to generate monoclonal antibodies to overcome the challenges of inflammatory disease. The …
Research shows new treatment could delay cancer progression in …
Dec 10, 2024 · ROCHESTER, Minn. — A new treatment is showing promise for people with high-risk smoldering multiple myeloma (SMM). This precancerous condition can progress to active multiple …
Study shows immune molecule may play key role in the progression of …
Nov 18, 2023 · Researchers have identified a protein expressed by immune cells that may play a key role in the development of amyotrophic lateral sclerosis.